Captrust Financial Advisors G1 Therapeutics, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $10,160 - $16,170	1,000 Added 100.0%	2,000 $20,000
Q3 2021 Nov 16, 2021	SELL	$13.16 - $22.47 $26,320 - $44,940	-2,000 Reduced 66.67%	1,000 $13,000
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $35,160 - $65,180	2,000 Added 200.0%	3,000 $72,000
Q4 2020 Feb 16, 2021	SELL	$10.99 - $20.4 $43,960 - $81,600	-4,000 Reduced 80.0%	1,000 $18,000
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $47,850 - $121,850	5,000 New	5,000 $119,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.